EddyCHsuehMD
General Surgery • Saint Louis, MOSurgical Oncology (Other than Breast)
Professor in the Department of Surgery, Division of General Surgery, at Saint Louis University School of Medicine
Dr. Hsueh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3655 Vista Ave
Saint Louis, MO 63110Phone+1 314-977-4440Fax+1 314-977-1630
Education & Training
SUNY Downstate Health Sciences UniversityResidency, Surgery, 1991 - 1996
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1996 - 2026
MO State Medical License 2003 - 2026
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 7 citationsBlocking senescence and tolerogenic function of dendritic cells induced by γδ Treg cells enhances tumor-specific immunity for cancer immunotherapy.Fusheng Si, Xia Liu, Yan Tao, Yuanqin Zhang, Feiya Ma
Journal for Immunotherapy of Cancer. 2024-04-05 - 2 citationsImpact of Hospital Volume on Utilization of Minimally Invasive Surgery for Gastric Cancer.Kristen Dougherty, Zidong Zhang, Grace Montenegro, Leslie Hinyard, Evan Xu
The American Surgeon. 2023-11-01 - 264 citationsNeoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright Jr, Kathleen J Yost
The New England Journal of Medicine. 2023-03-02
Press Mentions
Newly Published Independent, Prospective Study Reinforces Prognostic Accuracy of DecisionDx-Melanoma in Cutaneous MelanomaApril 11th, 2019
Grant Support
- Enhancement Of Immunogenicity Of Human Melanoma VaccineNational Cancer Institute2003–2005
- Enhancement Of Immunogenicity Of Human Melanoma VaccineNational Cancer Institute2000–2003
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
